This reply
Lin mark this message contains misinformation
originally written by Lin
新冠疫苗上市前,都有經過二/三期人體試驗,證實安全性可以被接受,因此目前國際上認為輝瑞疫苗的安全性是沒問題的。國際間新冠疫苗的研發、製造與分配,是由世界衛生組織、全球疫苗免疫聯盟(GAVI)、流行病防範創新聯盟(CEPI)共同成立「新冠肺炎疫苗全球取得機制(COVAX)」來進行,並不會特別請求購買中國滅活疫苗。

References

https://tfc-taiwan.org.tw/articles/5007

The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.